Prescient Therapeutics (ASX:PTX) - Key People
ASX:PTX · Directors, executives and key personnel · 12 month lookback
James McDonnell
Current
CEO
Mentioned in
Healthcare Wrap - Week 5 (26 Jan -> 30 Jan) 2026
31 Jan 2026
Prescient Therapeutics Advances PTX-100 with EMA Orphan Drug Status and Global Trial Expansion
30 Jan 2026
Prescient Therapeutics Gains EU Nod to Launch PTX-100 Phase 2a Trial in CTCL
15 Dec 2025
Prescient Secures EMA Orphan Drug Status for PTX-100 in CTCL
19 Nov 2025
Also Mentioned
People named in Prescient Therapeutics (ASX:PTX) articles over the last 12 months, by frequency.
Melanie Farris
· 4 articles
James Campbell
· 3 articles
Allen Ebens
· 3 articles
Ellen Feigal
· 3 articles
Gavin Shepherd
· 3 articles
Melanie Leydin
· 2 articles
Patrick Nelson
· 2 articles
Marissa Lim
· 2 articles
Christian Riedel
· 2 articles
Steven Yatomi-Clarke
· 1 article
Steven Engle
· 1 article
Dejan Radeski
· 1 article
Professor Miles Prince
· 1 article
Christina Scheffler
· 1 article
Said Sebti
· 1 article